Charles Schwab’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $846K | Sell |
250,949
-7,426
| -3% | -$25K | ﹤0.01% | 2949 |
|
|
2025
Q1 | $997K | Sell |
258,375
-6,300
| -2% | -$24.3K | ﹤0.01% | 2847 |
|
|
2024
Q4 | $1.63M | Buy |
264,675
+7,243
| +3% | +$44.7K | ﹤0.01% | 2742 |
|
|
2024
Q3 | $1.38M | Buy |
257,432
+77,472
| +43% | +$417K | ﹤0.01% | 2810 |
|
|
2024
Q2 | $603K | Buy |
179,960
+790
| +0.4% | +$2.65K | ﹤0.01% | 3116 |
|
|
2024
Q1 | $722K | Buy |
179,170
+3,525
| +2% | +$14.2K | ﹤0.01% | 2894 |
|
|
2023
Q4 | $465K | Buy |
175,645
+2,100
| +1% | +$5.57K | ﹤0.01% | 3094 |
|
|
2023
Q3 | $410K | Sell |
173,545
-55,261
| -24% | -$130K | ﹤0.01% | 3115 |
|
|
2023
Q2 | $1.44M | Sell |
228,806
-1,541
| -0.7% | -$9.71K | ﹤0.01% | 2653 |
|
|
2023
Q1 | $1.33M | Sell |
230,347
-565
| -0.2% | -$3.26K | ﹤0.01% | 2636 |
|
|
2022
Q4 | $2.37M | Buy |
230,912
+6,352
| +3% | +$65.2K | ﹤0.01% | 2512 |
|
|
2022
Q3 | $3.76M | Buy |
224,560
+89,785
| +67% | +$1.5M | ﹤0.01% | 2370 |
|
|
2022
Q2 | $1.89M | Buy |
134,775
+12,407
| +10% | +$174K | ﹤0.01% | 2582 |
|
|
2022
Q1 | $1.98M | Buy |
122,368
+3,812
| +3% | +$61.6K | ﹤0.01% | 2650 |
|
|
2021
Q4 | $2.54M | Buy |
118,556
+28,035
| +31% | +$600K | ﹤0.01% | 2622 |
|
|
2021
Q3 | $1.33M | Buy |
90,521
+2,756
| +3% | +$40.5K | ﹤0.01% | 2785 |
|
|
2021
Q2 | $1.75M | Buy |
+87,765
| New | +$1.75M | ﹤0.01% | 2759 |
|